Beverly Hills Private Wealth, LLC Myriad Genetics Inc Transaction History
Beverly Hills Private Wealth, LLC
- $495 Billion
- Q3 2024
A detailed history of Beverly Hills Private Wealth, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Beverly Hills Private Wealth, LLC holds 12,856 shares of MYGN stock, worth $166,613. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,856
Previous 15,647
17.84%
Holding current value
$166,613
Previous $383 Million
8.0%
% of portfolio
0.07%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding MYGN
# of Institutions
249Shares Held
90.6MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$196 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$134 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$87 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$67.1 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$61 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.05B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...